By Dr Annie Gabrielle Madden

Book Chapters

Madden A; Lennon P; Hogan C; Getty M; Hopwood M; Neale J; Treloar C, 2019, 'Patient-reported measures as a justice project through involvement of service-user researchers', in Aggleton P; Broom A; Moss J (ed.), Practical Justice: Principles, Practice and Social Change, Routledge, pp. 190 - 199, http://dx.doi.org/10.4324/9781351010498

O'Brien ML; Madden A, 2007, 'Knowledge, relationships and identity in research on drug use', in Researching the Margins: Strategies for Ethical and Rigorous Research With Marginalised Communities, pp. 45 - 65, http://dx.doi.org/10.1057/9780230224476

Journal articles

Bathish R; Madden A; Duff C; Ritter A, 2024, 'Guiding principles for breaking down drug-related stigma in academic writing', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104515

Olsen A; Gough C; Madden A; Maher L; Hudson S; Ward G; Higgs P, 2024, 'Ageing disgracefully with Jude Byrne: A special section recognising her life and work', Drug and Alcohol Review, 43, pp. 1037 - 1039, http://dx.doi.org/10.1111/dar.13891

Shaw G; Schaefer R; Schmidt HMA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V, 2023, 'Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00729-6

Madden A; Olsen A; Higgs P; Ward G; Gough C; Hudson S; Maher L, 2023, 'Vale Jude Byrne', Drug and Alcohol Review, 42, pp. 505 - 506, http://dx.doi.org/10.1111/dar.13631

Brener L; Caruana T; Broady T; Cama E; Ezard N; Madden A; Treloar C, 2022, 'Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs', Addictive Behaviors Reports, 15, pp. 100398, http://dx.doi.org/10.1016/j.abrep.2021.100398

Larney S; Madden A; Marshall AD; Martin NK; Treloar C, 2022, 'A gender lens is needed in hepatitis C elimination research', International Journal of Drug Policy, 103, http://dx.doi.org/10.1016/j.drugpo.2022.103654

Madden A; Lancaster K; Ritter A; Treloar C, 2021, 'Making legitimacy: Drug user representation in United Nations drug policy settings', International Journal of Drug Policy, 87, pp. 103014, http://dx.doi.org/10.1016/j.drugpo.2020.103014

Fraser S; Moore D; Farrugia A; Edwards M; Madden A, 2020, 'Exclusion and hospitality: the subtle dynamics of stigma in healthcare access for people emerging from alcohol and other drug treatment', Sociology of Health and Illness, 42, pp. 1801 - 1820, http://dx.doi.org/10.1111/1467-9566.13180

Farrugia A; Pienaar K; Fraser S; Edwards M; Madden A, 2020, 'Basic care as exceptional care: addiction stigma and consumer accounts of quality healthcare in Australia', Health Sociology Review, pp. 1 - 16, http://dx.doi.org/10.1080/14461242.2020.1789485

Seear K; Fraser S; Madden A, 2020, 'The Problem of the Subject: The Politics of Post-mortem Rights in the Aftermath of Drug-related Deaths', Australian Feminist Law Journal, 46, pp. 169 - 188, http://dx.doi.org/10.1080/13200968.2021.1885201

Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698

Brown G; Perry GE; Byrne J; Crawford S; Henderson C; Madden A; Lobo R; Reeders D, 2019, 'Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C elimination', International Journal of Drug Policy, 72, pp. 24 - 32, http://dx.doi.org/10.1016/j.drugpo.2019.05.025

Madden A; Hopwood M; Neale J; Treloar C, 2019, 'Acceptability of Patient-Reported Outcome and Experience Measures for Hepatitis C Treatment Among People Who Use Drugs', Patient, 12, pp. 259 - 265, http://dx.doi.org/10.1007/s40271-018-0332-6

Madden A; Hopwood M; Neale J; Treloar C, 2018, 'Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?', PLoS ONE, 13, pp. e0207226, http://dx.doi.org/10.1371/journal.pone.0207226

Brown G; Reeders D; Cogle A; Madden A; Kim J; O'Donnell D, 2018, 'A systems thinking approach to understanding and demonstrating the role of peer-led programs and leadership in the response to HIV and hepatitis C: Findings from the W3 project', Frontiers in Public Health, 6, http://dx.doi.org/10.3389/fpubh.2018.00231

Madden A; Hopwood M; Neale J; Treloar C, 2018, 'Beyond cure: Patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia', Harm Reduction Journal, 15, pp. 42, http://dx.doi.org/10.1186/s12954-018-0248-4

Madden A, 2018, 'Commentary on Madden et al. (2018): ‘It's not only about the destination… it's also about the journey!’ Consumer perspectives on a model of open-access MAT provision', Addiction, 113, pp. 1459 - 1460, http://dx.doi.org/10.1111/add.14273

Henderson C; Madden A; Kelsall J, 2017, '‘Beyond the willing & the waiting’ — The role of peer-based approaches in hepatitis C diagnosis & treatment', International Journal of Drug Policy, 50, pp. 111 - 115, http://dx.doi.org/10.1016/j.drugpo.2017.08.004

Quinn B; Seed C; Keller A; Maher L; Wilson D; Farrell M; Caris S; Williams J; Madden A; Thompson A; Pink J; Hellard ME, 2017, 'Re-examining blood donor deferral criteria relating to injecting drug use', International Journal of Drug Policy, 48, pp. 9 - 17, http://dx.doi.org/10.1016/j.drugpo.2017.05.058

Treloar C; Cama E; Brener L; Hopwood M; Dewit J; Madden A; Neale J, 2017, 'O11 Hepatitis C: stigma indicators and patient reported outcome measures for DAA treatment', Journal of Virus Eradication, 3, pp. 4 - 5, http://dx.doi.org/10.1016/s2055-6640(20)30894-3

Doyle JS; Grebely J; Spelman T; Alavi M; Matthews GV; Thompson AJ; Dore GJ; Hellard ME; Kaldor J; Marks P; Lloyd A; Haber P; French R; White P; Rawlinson W; Day C; Van Beek I; McCaughan G; Madden A; Dolan K; Farrell G; Crofts N; Sievert W; Baker D, 2016, 'Quality of life and social functioning during treatment of recent hepatitis C infection: A multi-centre prospective cohort', PLoS ONE, 11, pp. e0150655, http://dx.doi.org/10.1371/journal.pone.0150655

Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P; Acraman B, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003

Lancaster K; Santana L; Madden A; Ritter A, 2015, 'Stigma and subjectivities: Examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs', Drugs: Education, Prevention and Policy, 22, pp. 224 - 231, http://dx.doi.org/10.3109/09687637.2014.970516

Iversen J; Page K; Madden A; Maher L, 2015, 'HIV, HCV, and health-related harms among women who inject drugs: Implications for prevention and treatment', Journal of Acquired Immune Deficiency Syndromes, 69, pp. S176 - S181, http://dx.doi.org/10.1097/QAI.0000000000000659

Meurk C; Keane H; Fraser S; Madden A; Morphett K; Fraser D; Carter A; Lucke J; Hall WD, 2014, 'NEUROSCIENTIFIC ACCOUNTS OF ADDICTION: SOCIAL AND ETHICAL DIMENSIONS', DRUG AND ALCOHOL REVIEW, 33, pp. 9 - 9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Olsen A; Banwell C; Madden A, 2014, 'Contraception, punishment and women who use drugs', BMC Women's Health, 14, http://dx.doi.org/10.1186/1472-6874-14-5

White B; Madden A; Prins M; Hellard M; Wand H; Dore GJ; Page K; Maher L, 2014, 'Assessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study', Vaccine, 32, pp. 5460 - 5467, http://dx.doi.org/10.1016/j.vaccine.2014.07.091

Madden A; Wodak A, 2014, 'Australia’s response to HIV among people who inject drugs', AIDS Education and Prevention, 26, pp. 234 - 244, http://dx.doi.org/10.1521/aeap.2014.26.3.234

White B; Madden A; Hellard M; Kerr T; Prins M; Page K; Dore GJ; Maher L, 2013, 'Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs', Drug and Alcohol Review, 32, pp. 419 - 425, http://dx.doi.org/10.1111/dar.12000

Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x

Treloar C; Rance J; Madden A; Liebelt L, 2011, 'Evaluation of consumer participation demonstration projects in five australian drug user treatment facilities: The impact of individual versus organizational stability in determining project progress', Substance Use and Misuse, 46, pp. 969 - 979, http://dx.doi.org/10.3109/10826084.2010.540289

Maher L; White B; Hellard M; Madden A; Prins M; Kerr T; Page K, 2010, 'Candidate hepatitis C vaccine trials and people who inject drugs: Challenges and opportunities', Vaccine, 28, pp. 7273 - 7278, http://dx.doi.org/10.1016/j.vaccine.2010.08.085

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Fraser S; Hopwood MN; Madden A; Treloar C, 2009, '`Towards a Global Approach`-An overview of Harm Reduction 2008: IHRA`s 19th International Conference', International Journal of Drug Policy, 20, pp. 93 - 97, http://dx.doi.org/10.1016/j.drugpo.2008.08.001

Bryant J; Saxton M; Madden A; Bath N; Robinson S, 2008, 'Consumer participation in the planning and delivery of drug treatment services: The current arrangements', Drug and Alcohol Review, 27, pp. 130 - 137, http://dx.doi.org/10.1080/09595230701829397

Bryant J; Madden A; Bath N; Robinson S, 2008, 'Consumers' and providers' perspectives about consumer participation in drug treatment services: Is there support to do more? What are the obstacles?', Drug and Alcohol Review, 27, pp. 138 - 144

Winstock AR; Lea T; Madden A; Bath N, 2008, 'Knowledge about buprenorphine and methadone among those receiving treatment for opioid dependence', Drugs: Education, Prevention, and Policy, 15, pp. 395 - 409, http://dx.doi.org/10.1080/09687630701425865

Madden A; Lea T; Bath N; Winstock A, 2008, 'Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment', Drug and Alcohol Review, 27, pp. 671 - 678

Friedman SR; Cavalieri W; Crofts N; Walsh N; Madden A; Taylor A, 2007, 'Hepatitis C prevention and care for injecting drug users', International Journal of Drug Policy, 18, pp. 333 - 334, http://dx.doi.org/10.1016/j.drugpo.2007.06.003

Madden A; Cavalieri W, 2007, 'Hepatitis C prevention and true harm reduction', International Journal of Drug Policy, 18, pp. 335 - 337, http://dx.doi.org/10.1016/j.drugpo.2007.06.007

Back to profile page